AudioCure Receives Hearing Technology Innovator Award for AC102 in Therapeutics Category A Phase 2 clinical trial evaluating the efficacy, safety and tolerability of AC102 in patients with Sudden Sensorineural Hearing Loss is underway across Europe Dr. Reimar...
Reimar Schlingensiepen succeeds Prof. Hans Rommelspacher, the founder of AudioCure, as CEO. Rommelspacher will continue as CSO. AudioCure recently secured funding of about 9 million euros in a Series A financing round from Austrian MED-EL Elektromedizinische...
It is with great pleasure that we announce the relaunch of our corporate brand and website. The brand design has been refined and updated to reflect AudioCure’s innovative and forward-thinking outlook. Meanwhile, we hope that with its clear structure, easy navigation...
This website uses cookies. By clicking on the “Ok” button, you consent to our use of cookies as described in our Privacy Notice. If you continue to use this site we will assume that you agree with our Privacy Police.OkRead more
